Are insulin resistance surrogates, particularly the TyG index, associated with all-cause and cardiovascular mortality in populations with cardiometabolic multimorbidity?
The TyG index is a crucial prognostic marker for predicting mortality in patients with cardiometabolic multimorbidity, which may aid in developing management and intervention strategies.
This study emphasizes the prognostic significance of IR surrogates, particularly the TyG index, in predicting mortality among individuals with CMM. The TyG index constitutes a crucial element in the development of management and intervention strategies for these patients.
Zhang et al. (Wed,) studied this question.